Krebs Biochemicals and Industries Limited — Board Meeting, 04-11-2025: Outcome of Board Meeting

Krebs Biochemicals' board has approved the financial results for the quarter and half-year ended Sep 30, 2025. The company reported a Q2 loss of Rs 5.76 Cr on revenue of Rs 5.48 Cr. For the half-year, loss was Rs 11.47 Cr on revenue of Rs 9.65 Cr. The Vizag plant remains closed.